Advanced search
Publication Cover
Acta Oto-Laryngologica Case Reports Volume 8, 2023 - Issue 1
Submit an article Journal homepage
622
Views
1
CrossRef citations to date
0
Altmetric
Case Reports

Oral cavity cancer in two young patients with ulcerative colitis, a case report

Andries H. Groena Department of Otorhinolaryngology - Head and Neck Surgery, University Medical Center Utrecht, Utrecht, The NetherlandsCorrespondence[email protected]
,
Jacob A. de Rub Department of Otorhinolaryngology, Central Military Hospital, Utrecht, The Netherlands
,
Cindy Postmac Department of Gastroenterology and Hepatology, Central Military Hospital, Utrecht, The Netherlands
,
Gerben E. Breimerd Department of Pathology, University Medical Center Utrecht, Utrecht, The Netherlands
&
Johannes A. Rijkene Department of Head and Neck Surgical Oncology, University Medical Center Utrecht, Utrecht, The Netherlands
Pages 108-112 | Received 13 Apr 2023, Accepted 26 Jul 2023, Published online: 10 Aug 2023

References

  • Burisch J, Jess T, Martinato M, et al. The burden of inflammatory bowel disease in Europe. J Crohns Colitis. 2013;7(4):322–337. doi:10.1016/j.crohns.2013.01.010.
  • Ng SC, Shi HY, Hamidi N, et al. Worldwide incidence and prevalence of inflammatory bowel disease in the 21st century: a systematic review of Population-Based studies. Lancet. 2017;390(10114):2769–2778. doi:10.1016/S0140-6736(17)32448-0.
  • Beaugerie L, Itzkowitz SH. Cancers complicating inflammatory bowel disease. N Engl J Med. 2015;372(15):1441–1452. doi:10.1056/NEJMra1403718.
  • Desai B, Svirsky J. Oral cancer in a patient receiving mercaptopurine for ulcerative colitis. J Crohns Colitis. 2016;10(4):504–505. doi:10.1093/ecco-jcc/jjv236.
  • Li ACY, Warnakulasuriya S, Thompson RPH. Neoplasia of the tongue in a patient with crohn’s disease treated with azathioprine: case report. Eur J Gastroenterol Hepatol. 2003;15(2):185–187. doi:10.1097/00042737-200302000-00013.
  • Harjunen A, Puolakkainen E, Laine HK, et al. Men with Crohn’s disease may have an increased risk for head and neck squamous cell carcinoma - a nationwide register study. Clin Oral Investig. 2023;27(2):625–630. doi:10.1007/s00784-022-04762-w.
  • Chen G, Xie J, Liang T, et al. Inflammatory bowel disease promote oral cancer and pharyngeal cancer: new evidence of Mendelian randomization. Acta Otolaryngol. 2022;142(2):191–196. doi:10.1080/00016489.2022.2035431.
  • Sung H, Ferlay J, Siegel RL, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209–249. doi:10.3322/caac.21660.
  • Kumar M, Nanavati R, Modi TG, et al. Oral cancer: etiology and risk factors: a review. J Cancer Res Ther. 2016;12(2):458–463. doi:10.4103/0973-1482.186696.
  • Ang KK, Harris J, Wheeler R, et al. Human papillomavirus and survival of patients with oropharyngeal cancer. N Engl J Med. 2010;363(1):24–35. doi:10.1056/NEJMoa0912217.
  • Hübbers CU, Akgül B. HPV and cancer of the oral cavity. Virulence. 2015;6(3):244–248. doi:10.1080/21505594.2014.999570.
  • Giagkou E, Christodoulou DK, Katsanos KH. Mouth cancer in inflammatory bowel diseases. Oral Dis. 2016;22(4):260–264. doi:10.1111/odi.12420.
  • Katsanos KH, Roda G, McBride RB, et al. Increased risk of oral cancer in patients with inflammatory bowel diseases. Clin Gastroenterol Hepatol. 2016;14(3):413–420. doi:10.1016/j.cgh.2015.09.041.
  • Nissen LHC, Derikx LAAP, Jacobs AME, et al. Risk factors and clinical outcomes of head and neck cancer in inflammatory bowel disease: a nationwide cohort study. Inflamm.Bowel Dis. 2018;24(9):2015–2026. doi:10.1093/ibd/izy096.
  • Mowery AJ, Conlin MJ, Clayburgh DR. Elevated incidence of head and neck cancer in solid organ transplant recipients. Head Neck. 2019;41(11):4009–4017. doi:10.1002/hed.25937.
  • Quezada SM, McLean LP, Cross RK. Adverse events in IBD therapy: the 2018 update. Expert Rev Gastroenterol Hepatol. 2018;12(12):1183–1191. doi:10.1080/17474124.2018.1545574.
  • Nijakowski K, Rutkowski R, Eder P, et al. Changes in salivary parameters of oral immunity after biologic therapy for inflammatory bowel disease. Life.(Basel). 2021;11(12):1409. doi:10.3390/life11121409.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.